Literature DB >> 3394704

Congenital heart disease: incidence in the first year of life. The Alberta Heritage Pediatric Cardiology Program.

R G Grabitz1, M R Joffres, R L Collins-Nakai.   

Abstract

The Heritage Pediatric Cardiology Program is a regional study of patients with congenital heart disease in northern and central Alberta, Canada. Cases of congenital heart disease were confirmed by clinical examination by a pediatric cardiologist plus echocardiography (noninvasive criteria) with or without cardiac catheterization, cardiac surgery, or autopsy (invasive criteria). From 1981 to 1984 inclusive, 573 confirmed cases of congenital heart disease occurred in a population of 103,411 livebirths (5.54 and 3.36/1,000 livebirths using the noninvasive and the invasive criteria, respectively). This is significantly higher (p less than 0.0001) than the rates found in the Baltimore-Washington Infant Study (3.69 and 2.38/1,000 livebirths for the noninvasive and invasive methods, respectively) or the New England Regional Infant Cardiac Program (2.20/1,000 livebirths using invasive methods). Although some lesions occur at rates similar to those found in these other registries, there are 4.4 times more double outlet right ventricles and 2.9 times more atrial septal defects in northern and central Alberta than were found in the New England Regional Infant Cardiac Program (p less than 0.001). The overall congenital heart disease rate has increased 47% between 1981 and 1984, and the rate of ventricular septal defects has doubled during the same period in northern and central Alberta. No methodological bias was found to explain these higher and increasing rates.

Entities:  

Mesh:

Year:  1988        PMID: 3394704     DOI: 10.1093/oxfordjournals.aje.a114978

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  17 in total

1.  Risk factors for cardiovascular malformations in Finland.

Authors:  J Tikkanen; O P Heinonen
Journal:  Eur J Epidemiol       Date:  1990-12       Impact factor: 8.082

2.  Incidences and sociodemographics of specific congenital heart diseases in the United States of America: an evaluation of hospital discharge diagnoses.

Authors:  Alexander Egbe; Santosh Uppu; Annemarie Stroustrup; Simon Lee; Deborah Ho; Shubhika Srivastava
Journal:  Pediatr Cardiol       Date:  2014-02-22       Impact factor: 1.655

Review 3.  Postoperative residua and sequelae in adults with repaired tetralogy of Fallot.

Authors:  Munetaka Masuda
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-04-26

Review 4.  Incidence of congenital heart disease: I. Postnatal incidence.

Authors:  J I Hoffman
Journal:  Pediatr Cardiol       Date:  1995 May-Jun       Impact factor: 1.655

5.  Risk factors for congenital heart diseases in Alexandria, Egypt.

Authors:  A Bassili; S A Mokhtar; N I Dabous; S R Zaher; M M Mokhtar; A Zaki
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

6.  Population-based treated prevalence of congenital heart disease in a pediatric cohort.

Authors:  C Osborne Shuler; George B Black; Jeanette M Jerrell
Journal:  Pediatr Cardiol       Date:  2012-09-14       Impact factor: 1.655

7.  Influence of ethnic origin on the pattern of congenital heart defects in the first year of life.

Authors:  M Sadiq; O Stümper; J G Wright; J V De Giovanni; C Billingham; E D Silove
Journal:  Br Heart J       Date:  1995-02

8.  Poor outcome of very low birthweight babies with serious congenital heart disease.

Authors:  Z Kecskes; D W Cartwright
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-07       Impact factor: 5.747

9.  Spectrum of congenital heart disease in a tropical environment: an echocardiography study.

Authors:  Mahmoud U Sani; Mariya Mukhtar-Yola; Kamilu M Karaye
Journal:  J Natl Med Assoc       Date:  2007-06       Impact factor: 1.798

10.  Genetic study of congenital heart defects in Northern Ireland (1974-1978).

Authors:  E J Hanna; N C Nevin; J Nelson
Journal:  J Med Genet       Date:  1994-11       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.